- Affinia Therapeutics, a private gene therapy firm, showcased its BAG3 DCM treatment at a major cardiology conference but remains unlisted for public investment. - The therapy targets a rare genetic ...

- Vylor VYLR+0.49% (VYLR) trades at 48x earnings despite generating only $1.2B in operating cash flow, far exceeding its ...

Archaeologists have proposed dates for the first people in the Americas that span more than 100,000 years, from roughly ...

Nirman Agri Genetics Limited was incorporated as Nirman Agri Genetics Private Limited on August 19 2020 with Registrar of Companies Mumbai. The Company changed to Public Limited to 'Nirman Agri ...

China stands as a significant player in the global dairy industry, with an annual milk production of approximately 36 million tons. The country's processing capacity is about 60.18 million tons per ...

JK Agri Genetics Limited was incorporated as a Public limited company in 2000. The company is mainly agri-genetics engaged in research and development production processing and marketing of high ...

Growth opportunities center on outsourced testing, emerging-market labs and partnerships, plus automated, high-throughput and animal-free in vitro assaysDublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- ...

Complete Illumina Inc. stock information by Barron's. View real-time ILMN stock price and news, along with industry-best analysis.

Phelan-McDermid syndrome, a rare genetic disorder in which many patients also have autism, may affect about 1 in 7,300 people ...

Pacific Biosciences of California's business model struggles to gain traction versus larger, profitable competitors like Illumina. Read why PACB stock is a buy.